A comparison of losartan/hydrochlorothiazide vs combination therapy with an angiotensin II receptor antagonist and a calcium channel blocker in hypertensive patients with cardiac hypertrophy

Trial Profile

A comparison of losartan/hydrochlorothiazide vs combination therapy with an angiotensin II receptor antagonist and a calcium channel blocker in hypertensive patients with cardiac hypertrophy

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary) ; Angiotensin receptor antagonists; Calcium channel antagonists
  • Indications Hypertension; Left ventricular hypertrophy
  • Focus Therapeutic Use
  • Acronyms E-SEARCH
  • Most Recent Events

    • 16 Nov 2012 Status changed from recruiting to completed.
    • 04 Oct 2012 Primary endpoint 'Left-ventricular-muscle-mass-index' has not been met.
    • 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top